Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

NCT04807777 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Departure of the original investigator

Conditions

Advanced Cutaneous Squamous Cell Carcinoma

Interventions

DRUG: Ruxolitinib

Sponsor

Columbia University

Collaborators

[object Object]